ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATX Amplia Therapeutics Limited

0.076
0.00 (0.00%)
Mar 04 2024 - Closed
Delayed by 20 minutes

Amplia Therapeutics Financial Summary

The current ATX market cap is 14.74M. The company's latest EPS is NZD -0.0322 and P/E is -2.48.

Year End March 30 2023 20192020202120222023
NZD ($)NZD ($)NZD ($)NZD ($)NZD ($)
Total Revenue 50k34k1.59M1.98M1.19M
Operating Income -1.9M-2.23M-2.28M-3.64M-6.29M
Net Income -1.87M-2.22M-2.28M-3.64M-6.24M
Year End March 30 2023 20192020202120222023
NZD ($)NZD ($)NZD ($)NZD ($)NZD ($)
Total Assets 9.19M9.12M10.88M24.48M18.68M
Total Liabilities 527k511k539k2.64M2.85M
Total Equity 8.66M8.61M10.34M21.85M15.84M

Cash Flow

Year End March 30 2023 20192020202120222023
NZD ($)NZD ($)NZD ($)NZD ($)NZD ($)
Operating -987k-2.09M-2.92M-4.4M-5.29M
Investing -3k N/A -5k-26k-58k
Financing -12k1.96M3.66M17.19M-84k
Market Cap 14.74M
Price to Earnings Ratio -2.48
Price to Sales Ratio 13.11
Price to Cash Ratio 1.68
Price to Book Ratio 0.98
Dividend Yield -

Share Statistics

Shares Outstanding 194.01M
Average Volume (1 week) 32.83k
Average Volume (1 Month) 59.4k
52 Week Change -12.64%
52 Week High 0.115
52 Week Low 0.062
Spread (Intraday) 0.01 (7.89%)

Company Info

Company Name Amplia Therapeutics Limited
Address level 21
melbourne, victoria 3000
Website https://www.ampliatx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock